CTIS.eu › Cities › Italy › Rozzano
Rozzano
Italy
692 total trials
320 recruiting
2022-500797-34-00
4
2018-12-17
Treatment of participants with positive cancer for HRRm or HRD.
2023-509061-20-00
9
2018-11-22
Advanced solid tumors
2024-511553-22-00
5
2018-10-05
Moderately to Severely Active Crohn's Disease
2023-510426-33-00
5
2018-09-27
Moderately to Severely Active Crohn's Disease
2024-511533-35-00
4
2018-09-03
Mantle Cell Lymphoma
2023-506564-14-00
1
2018-05-16
Relapsed and refractory multiple myeloma (RRMM)
2023-509595-42-00
5
2017-10-31
Gastric and gastroesophageal junction (GEJ) adenocarcinoma
2024-511660-89-00
4
2017-06-09
metastatic castration resistant prostate cancer (mCRPC)
2022-500400-22-00
5
2016-06-23
Hodgkin lymphoma
2024-514815-92-00
5
2015-07-16
Ulcerative colitis
2024-517856-36-00
5
2015-03-09
Completely resected primary stage IB (≥ 4cm), II and IIIA non-small ce
2023-506419-16-00
5
2013-01-08
Advanced Classical Hodgkin Lymphoma
2022-501353-37-00
5
Reversal of anticoagulation effect in patients on a FXa inhibitor (api
2022-502414-84-00
3
Hemophilia A
2023-503348-15-00
7
Hodgkin lymphoma or non-Hodgkin lymphoma
2023-506487-13-00
5
Hormone receptor-positive, her2-negative advanced/metastatic breast ca
2023-508684-68-00
9
Advanced solid tumor
2023-508744-22-00
5
Post-COVID-19 Postural Orthostatic Tachycardia Syndrome
2024-515393-27-00
4
Nonsquamous non-small cell lung cancer
2025-521600-21-00
1
mature B-Cell malignancies
Showing 673–692 of 692 trials